Advancements in Alzheimer's Blood Biomarkers

This chapter explores the progress in blood-based biomarkers for diagnosing Alzheimer's disease, presenting them as less invasive and more cost-effective alternatives to traditional methods. It discusses the accuracy and clinical application of specific biomarkers, emphasizing the importance of predefined cutoffs and their robust performance in primary care settings. Additionally, it addresses the complexities and implications of integrating these tests into standard clinical evaluations to avoid misdiagnoses.